Roflumilast cream is a potent and selective PDE4 inhibitor, modulating cyclic adenosine monophosphate levels to reduce pro-inflammatory cytokines and thereby lessening inflammation and normalizing keratinocyte proliferation.7 We propose that this normalizing of keratinocyte proliferation is what gives it efficacy in LS. This evidence concerns the gene PDE4A and Leigh syndrome.